{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T03:35:40Z","timestamp":1772768140152,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"crossref","award":["BIO2014-60305R"],"award-info":[{"award-number":["BIO2014-60305R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"crossref"}]},{"name":"BACFITERed","award":["SAF2014-56716-REDT"],"award-info":[{"award-number":["SAF2014-56716-REDT"]}]},{"DOI":"10.13039\/100012818","name":"Comunidad Aut\u00f3noma de Madrid","doi-asserted-by":"crossref","award":["S2010-BMD-2312"],"award-info":[{"award-number":["S2010-BMD-2312"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC-2012-ADG_20120314"],"award-info":[{"award-number":["ERC-2012-ADG_20120314"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biotechnology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jbiotec.2016.07.025","type":"journal-article","created":{"date-parts":[[2016,7,31]],"date-time":"2016-07-31T09:25:29Z","timestamp":1469957129000},"page":"58-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Characterization of nanobodies binding human fibrinogen selected by E. coli display"],"prefix":"10.1016","volume":"234","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1359-2853","authenticated-orcid":false,"given":"Valencio","family":"Salema","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"L\u00f3pez-Guajardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0764-7408","authenticated-orcid":false,"given":"Carlos","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Menc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5920-0638","authenticated-orcid":false,"given":"Luis \u00c1ngel","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbiotec.2016.07.025_bib0005","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nri2747","article-title":"Strategies and challenges for the next generation of therapeutic antibodies","volume":"10","author":"Beck","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0010","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1365-2958.1991.tb00790.x","article-title":"Type 1 fimbriae mutants of Escherichia coli K12: characterization of recognized afimbriate strains and construction of new fim deletion mutants","volume":"5","author":"Blomfield","year":"1999","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0015","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.1128\/JB.00458-09","article-title":"Role of periplasmic chaperones and BamA (YaeT\/Omp85) in folding and secretion of intimin from enteropathogenic Escherichia coli strains","volume":"191","author":"Bodel\u00f3n","year":"2009","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev-chembioeng-061010-114142","article-title":"Engineering antibodies for cancer therapy","volume":"2","author":"Boder","year":"2011","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bios.2013.08.055","article-title":"Disposable amperometric magnetoimmunosensors using nanobodies as biorecognition element. Determination of fibrinogen in plasma","volume":"52","author":"Campuzano","year":"2014","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0030","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nprot.2006.94","article-title":"Isolating and engineering human antibodies using yeast surface display","volume":"1","author":"Chao","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0035","doi-asserted-by":"crossref","first-page":"064101","DOI":"10.1063\/1.4901348","article-title":"Smartphone-interfaced lab-on-a-chip devices for field-deployable enzyme-linked immunosorbent assay","volume":"8","author":"Chen","year":"2014","journal-title":"Biomicrofluidics"},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/B978-0-12-381262-9.00003-3","article-title":"Role of fibrin structure in thrombosis and vascular disease","volume":"83","author":"Cilia La Corte","year":"2011","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nbt785","article-title":"Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library","volume":"21","author":"Feldhaus","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0050","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.molimm.2015.04.001","article-title":"In vivo imaging with antibodies and engineered fragments","volume":"67","author":"Freise","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0055","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2249.2011.04427.x","article-title":"Antibody fragments as tools in crystallography","volume":"165","author":"Griffin","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0060","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1631\/jzus.2005.B1045","article-title":"Acute phase reaction and acute phase proteins","volume":"6","author":"Gruys","year":"2005","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0065","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1021\/ac2030199","article-title":"Point of care diagnostics: status and future","volume":"84","author":"Gubala","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0070","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ygyno.2014.12.041","article-title":"Plasma fibrinogen levels in patients with benign and malignant ovarian tumors","volume":"136","author":"Hefler-Frischmuth","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0075","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nbt1142","article-title":"Engineered antibody fragments and the rise of single domains","volume":"23","author":"Holliger","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0080","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/nbt1126","article-title":"Selecting and screening recombinant antibody libraries","volume":"23","author":"Hoogenboom","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jcv.2010.02.018","article-title":"Evaluation of a rapid, point-of-care test device for the diagnosis of hepatitis C infection","volume":"48","author":"Lee","year":"2010","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0090","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/nbt1194-1107","article-title":"Construction and characterization of a set of E. coli strains deficient in all known loci affecting the proteolytic sability of secreted recombinant proteins","volume":"12","author":"Meerman","year":"1994","journal-title":"Nat. Biotech."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0095","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","article-title":"Nanobodies: natural single-domain antibodies","volume":"82","author":"Muyldermans","year":"2013","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0100","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1006\/abio.1998.2937","article-title":"Equilibrium analysis of high affinity interactions using BIACORE","volume":"265","author":"Myszka","year":"1998","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0105","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0161-5890(83)90090-1","article-title":"Induction of fibrin-specific antibodies by immunization with synthetic peptides that correspond to amino termini of thrombin cleavage sites","volume":"20","author":"Pacella","year":"1983","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0110","doi-asserted-by":"crossref","first-page":"R114","DOI":"10.1186\/ar3840","article-title":"Elevated levels of fibrinogen-derived endogenous citrullinated peptides in synovial fluid of rheumatoid arthritis patients","volume":"14","author":"Raijmakers","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0115","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.dld.2007.09.005","article-title":"Performance of a new rapid whole blood coeliac test in adult patients with low prevalence of endomysial antibodies","volume":"39","author":"Raivio","year":"2007","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0120","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/01.STR.0000169931.96670.fc","article-title":"Prognostic impact of fibrinogen in carotid atherosclerosis: nonspecific indicator of inflammation or independent predictor of disease progression?","volume":"36","author":"Sabeti","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0125","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.3390\/s8084669","article-title":"Antibody fragments as probe in biosensor development","volume":"8","author":"Saerens","year":"2008","journal-title":"Sensors"},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0130","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pep.2013.07.001","article-title":"High yield purification of nanobodies from the periplasm of E. coli as fusions with the maltose binding protein","volume":"91","author":"Salema","year":"2013","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0135","doi-asserted-by":"crossref","first-page":"e75126","DOI":"10.1371\/journal.pone.0075126","article-title":"Selection of single domain antibodies from immune libraries displayed on the surface of E. coli cells with two beta-domains of opposite topologies","volume":"8","author":"Salema","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0140","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-1759(97)00087-2","article-title":"Isolation of cell surface-specific human monoclonal antibodies using phage display and magnetically-activated cell sorting: applications in immunohematology","volume":"206","author":"Siegel","year":"1997","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0145","first-page":"317","article-title":"Plasma fibrinogen level may predict critical coronary artery stenosis in young adults with myocardial infarction","volume":"16","author":"Tatli","year":"2009","journal-title":"Cardiol. J."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0150","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/jclinpath-2015-203356","article-title":"The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma","volume":"69","author":"Troppan","year":"2016","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0155","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2958.2004.04014.x","article-title":"Structural tolerance of bacterial autotransporters for folded passenger protein domains","volume":"52","author":"Veiga","year":"2004","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0160","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1055\/s-0037-1613888","article-title":"A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation","volume":"83","author":"Watzke","year":"2000","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0165","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev.iy.12.040194.002245","article-title":"Making antibodies by phage display technology","volume":"12","author":"Winter","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jbiotec.2016.07.025_bib0170","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3109\/07388551.2014.958978","article-title":"Phage antibody display libraries: a powerful antibody discovery platform for immunotherapy","volume":"36","author":"Zhao","year":"2016","journal-title":"Crit. Rev. Biotechnol."}],"container-title":["Journal of Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168165616314353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168165616314353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T02:25:53Z","timestamp":1589682353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168165616314353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":34,"alternative-id":["S0168165616314353"],"URL":"https:\/\/doi.org\/10.1016\/j.jbiotec.2016.07.025","relation":{},"ISSN":["0168-1656"],"issn-type":[{"value":"0168-1656","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of nanobodies binding human fibrinogen selected by E. coli display","name":"articletitle","label":"Article Title"},{"value":"Journal of Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbiotec.2016.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}